DexCom
DXCM74.5400.80% ( -0.600 )
Q1 FY2026 EarningsQ2 2026 revenue reached $1.31B, up 13% YoY on a reported basis and 12% organically. Non-GAAP operating margin expanded significantly to 25.1%, a 590bps increase YoY, driven by gross margin improvement to 64.1% (+400bps). Net income rose to $249.1M with non-GAAP diluted EPS of $0.70. Management raised the midpoint of FY 2026 revenue guidance to $5.18-$5.25B (11-13% growth) and increased margins outlook across the board.
Financial report interval: 2025.12.31 - 2026.03.31
Preview: DexCom(DXCM) predict that the Revenue is 1.192 B (+15.05%), Beat estimate;the EBIT is 264.4 M (+84.77%), Beat estimate;the EPS is 0.51 (+88.89%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.19B15.05%
1.17B13.39%
+0.02B1.66%
EBITExceed expectations
0.26B84.77%
0.22B51.92%
+0.05B32.85%
EPSExceed expectations
0.5188.89%
0.452967.73%
+0.057121.16%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateJul 30, 2026
Estimate Revenue1.29 B
Estimate EBIT284.64 M
Estimate EPS0.603
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf